SavedAdd your journal

Journals / Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 2

Development in antiviral drugs and the assessment

Antiviral ilaçlardaki gelişmeler ve değerlendirilmesi

Banpiny Pal Wath DAR
Zehra ÖKSÜZ
Öztekin ALGÜL
Pages
160–170
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, antiviral drugs used during the treatment, differences and properties of these drugs was tried to be revealed by literature and the latest update on developments related to antiviral drugs was reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of antiviral therapy is to minimize the viral disease symptoms, infectiousness and shorten the treatment process.
📊
Key Findings & Data:Antivirals act differently on viral replication cycle steps.
💡
Conclusion & Impact:In this study, antiviral drugs used during the treatment, differences and properties of these drugs was tried to be revealed by literature and the latest update on developments related to antiviral drugs was reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Virüs · viral replikasyon · viral enfeksiyon

Abstract

The aim of antiviral therapy is to minimize the viral disease symptoms, infectiousness and shorten the treatment process. Antivirals act differently on viral replication cycle steps. However, nowadays, antiviral therapy is not available for all viral infections. Most antiviral drugs used in the treatment are effective in treating infections caused by HIV, herpes viruses, hepatitis B and C viruses, and influenza A and B viruses. Owing to viruses are mandatory, intracellular parasites, it is not very easy to find targets that prevent viral replication without damaging the host cell, as opposed to other antimicrobial drugs. Therefore, advances in treatment with antiviral drugs have been more lingering compared to antibacterial and antifungal drugs. This situation still continues today. In this study, antiviral drugs used during the treatment, differences and properties of these drugs was tried to be revealed by literature and the latest update on developments related to antiviral drugs was reviewed.

Özet

Antiviral tedavinin amacı, viral hastalık semptomları ile bulaşıcılığı en alt düzeye indirmek ve tedavi sürecini kısaltmaktır. Antiviraller viral replikasyon basamaklarına farklı şekillerde etki ederler. Ancak günümüzde, antiviral tedavi tüm viral enfeksiyonlar için bulunmamaktadır. Tedavide kullanılan antiviral ilaçların çoğu, HIV, herpes virüsleri, hepatit B ve C virüsleri ve influenza A ve B virüslerinin neden olduğu enfeksiyonların tedavisinde etkindir. Virüslerin zorunlu, hücre içi parazitler olması nedeniyle, konak hücreye zarar vermeden viral replikasyonu önleyen hedefler bulmak diğer antimikrobiyal ilaçların aksine çok kolay değildir. Bu nedenle antiviral tedavideki gelişmeler gerek antibakteriyel gerekse antifungallere göre daha yavaş ilerleyen bir süreç olmuştur. Bu süreç günümüzde hala devam etmektedir. Bu çalışmada, viral tedavide kullanılan antiviral ilaçlar, bu ilaçların farklılıkları ve ilaçların özellikleri literatür verilerine dayanılarak ortaya konulmuş, antiviral ilaçlarla ilgili gelişmelere ait güncel bilgiler derlenmiştir.

🔖

Cite This Article

DAR, B. P. W., ÖKSÜZ, Z., ALGÜL, Ö. (2019). Development in antiviral drugs and the assessment. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi, Cilt: 9 - Sayı: 2, 160–170. https://ajindex.com/articles/275706

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Antonelli G, Pistello M. Virology: a scientific discipline facing new challenges. Clin Microbiol Infect 2019;25(2):133-135
  2. Graham L. Patrick, An Introduction to Medicinal Chemistery. 5th Edition; In: Patrick L. P., editors. Antiviral Agents. New York: OXFORD University Press; 2012. pp:468-513
  3. Wohl S, Schaffner SF, Sabeti PC. Genomic Analysis of Viral Outbreaks. Annu Rev Virol 2016;3(1):173-195
  4. Kates JR, McAuslan BR. Poxvirus DNA-dependent RNA polymerase. Proceedings of the National Academy of Sciences 1967;58:134–141
  5. Oxford JS, Logan IS, Potter CW. In vivo selection of an influenza A2 strain resistant to amantadine. Nature 1970;226:82–83
  6. Prusoff WH. Discussion of the possible mechanisms of action of 5-iodo-2′-deoxyuridine (IDU, IUDR) and chymotrypsin in the treatment of herpes simplex keratitis. Transactions - American Academy of Ophthalmology & Otolaryngology 1963;67:707–709
  7. Hermann EC, Hermann JA. A working hypothesis – virus resistance development as an indicator of specific antiviral activity. Annals of the New York Academy of Sciences 1979;284:632–637
  8. Littler E, Oberg B. Achievements and challenges in antiviral drug discovery. Antivir Chem Chemother 2005;16(3):155-68
  9. Schaeffer HJ, et al. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 1978; 272:583–585
  10. Field HJ, De Clercq. E Antiviral drugs – a short history of their discovery and development. Microbiology Today 2004;31:58–61
  11. De Chassey B, et al. New horizons for antiviral drug discovery from virus-host protein interaction networks. Curr Opin Virol. 2012;2(5):606-13
  12. De Clercq E. Molecular targets for antiviral agents. J Pharmacol Exp Ther. 2001; 297(1):1-10
  13. Ustaçelebi Ş. Virüslerin morfolojisi ve genel özellikleri. In: Ustaçelebi, Ş editors. Temel ve Klinik mikrobiyoloji. Ankara: Güneş kitapevi;1999. pp:746
  14. Berdis AJ. DNA Polymerases as Therapeutic Targets. Biochemistry 2008;47(32): 8253–8260
  15. Said ZN, Abdelwahab KS. Antiviral Replication Agents. In: Rosas-Acosta, G. editors. Chapter 6. Antiviral Replication Agents. London: Intech;2013:127144
  16. Zoulim F, Lebosse F, Levrero M. Current treatments for chronic hepatitis B virüs infection. Current opinion in Virology 2016;18:109-16
  17. McKnight KL, Heinz BA. RNA as a target for developing antivirals. Antivir Chem Chemother 2003;14(2):61-73
  18. Beale JM. Wilson and Gisvold’s textbook of Organic Medicinal and Pharmaceutical Chemistry. In: Beale JM, Blo